FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

BA Brown

Research Profile

Disorders

Chemicals & Drugs

Physiology

Living Beings

Procedures

Co-author Network

Publications

TOP 3
Franz-Christoph Bange; BA Brown; C Smaczny; Richard J Wallace Jr; Erik C Böttger
Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic.
David E Griffith; BA Brown; William M Girard; B E Griffith; Leslie Couch; Richard J Wallace Jr
Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.
David E Griffith; BA Brown; P Cegielski; DT Murphy; Richard J Wallace
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of BA Brown (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Franz-Christoph Bange; BA Brown; C Smaczny; Richard J Wallace Jr; Erik C Böttger
Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(11):1648-50.
2001: David E Griffith; BA Brown; William M Girard; B E Griffith; Leslie Couch; Richard J Wallace Jr
Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(11):1547-53.
2000: David E Griffith; BA Brown; P Cegielski; DT Murphy; Richard J Wallace
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(2):288-92.
1999: BA Brown; B Springer; VA Steingrube; Rebecca W Wilson; G E Pfyffer; Maria J Garcia; M C Menendez; B Rodriguez-Salgado; Kenneth C Jost; Sher H Chiu; GO Onyi; Erik C Böttger; Richard J Wallace
Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy.
International journal of systematic bacteriology 1999;49 Pt 4():1493-511.
1999: BA Brown; JO Lopes; Rebecca W Wilson; J M Costa; Agueda Castagna de Vargas; Sydney Hartz Alves; C Klock; GO Onyi; Richard J Wallace
Disseminated Nocardia pseudobrasiliensis infection in a patient with AIDS in Brazil.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(1):144-5.
1998: Richard J Wallace; Y Zhang; BA Brown; D Dawson; DT Murphy; R Wilson; David E Griffith
Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis.
American journal of respiratory and critical care medicine 1998;158(4):1235-44.
1998: David E Griffith; BA Brown; DT Murphy; William M Girard; Leslie Couch; Richard J Wallace
Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients.
The Journal of infectious diseases 1998;178(1):121-6.
1998: Therdsak Prammananan; Peter Sander; BA Brown; K Frischkorn; GO Onyi; Yansheng Zhang; Erik C Böttger; Richard J Wallace
A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae.
The Journal of infectious diseases 1998;177(6):1573-81.
1998: Richard J Wallace; BA Brown; D E Griffith
Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria.
Annual review of microbiology 1998;52():453-90.
1998: Rebecca W Wilson; VA Steingrube; BA Brown; Richard J Wallace
Clinical application of PCR-restriction enzyme pattern analysis for rapid identification of aerobic actinomycete isolates.
Journal of clinical microbiology 1998;36(1):148-52.
1997: Yansheng Zhang; M Rajagopalan; BA Brown; Richard J Wallace
Randomly amplified polymorphic DNA PCR for comparison of Mycobacterium abscessus strains from nosocomial outbreaks.
Journal of clinical microbiology 1997;35(12):3132-9.
1997: Rebecca W Wilson; VA Steingrube; BA Brown; Zeta Blacklock; Kenneth C Jost; A McNabb; WD Colby; J R Biehle; J L Gibson; Richard J Wallace
Recognition of a Nocardia transvalensis complex by resistance to aminoglycosides, including amikacin, and PCR-restriction fragment length polymorphism analysis.
Journal of clinical microbiology 1997;35(9):2235-42.
1997: BA Brown; David E Griffith; William M Girard; J Levin; Richard J Wallace
Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):958-64.
1997: VA Steingrube; Rebecca W Wilson; BA Brown; Kenneth C Jost; Zeta Blacklock; J L Gibson; Richard J Wallace
Rapid identification of clinically significant species and taxa of aerobic actinomycetes, including Actinomadura, Gordona, Nocardia, Rhodococcus, Streptomyces, and Tsukamurella isolates, by DNA amplification and restriction endonuclease analysis.
Journal of clinical microbiology 1997;35(4):817-22.
1997: BA Brown; Richard J Wallace; David E Griffith; R Warden
Clarithromycin-associated digoxin toxicity in the elderly.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(1):92-3.
1996: David E Griffith; BA Brown; Richard J Wallace
Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(6):1321-2.
1996: David E Griffith; BA Brown; W M Girard; D T Murphy; Richard J Wallace
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(5):983-9.
1996: A Meier; L Heifets; Richard J Wallace; Yansheng Zhang; BA Brown; Peter Sander; Erik C Böttger
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population.
The Journal of infectious diseases 1996;174(2):354-60.
1996: Richard J Wallace; A Meier; BA Brown; Yansheng Zhang; Peter Sander; GO Onyi; Erik C Böttger
Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus.
Antimicrobial agents and chemotherapy 1996;40(7):1676-81.
1996: Richard J Wallace; BA Brown; David E Griffith; W M Girard; D T Murphy
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
American journal of respiratory and critical care medicine 1996;153(6 Pt 1):1766-72.
1996: BA Brown; Richard J Wallace; GO Onyi
Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.
Antimicrobial agents and chemotherapy 1996;40(4):874-8.
1995: VA Steingrube; BA Brown; J L Gibson; Rebecca W Wilson; J Brown; Z Blacklock; Kenneth C Jost; S Locke; R F Ulrich; Richard J Wallace
DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex.
Journal of clinical microbiology 1995;33(12):3096-101.
1995: David E Griffith; BA Brown; W M Girard; Richard J Wallace
Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(3):594-8.
1995: Richard J Wallace; BA Brown; Z Blacklock; R Ulrich; Kenneth C Jost; June M Brown; M M McNeil; GO Onyi; VA Steingrube; J Gibson
New Nocardia taxon among isolates of Nocardia brasiliensis associated with invasive disease.
Journal of clinical microbiology 1995;33(6):1528-33.
1995: BA Brown; Richard J Wallace; David E Griffith; W Girard
Clarithromycin-induced hepatotoxicity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(4):1073-4.
1995: Richard J Wallace; BA Brown; David E Griffith; W Girard; K Tanaka
Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection.
The Journal of infectious diseases 1995;171(3):747-50.
1995: VA Steingrube; J L Gibson; BA Brown; Yansheng Zhang; Rebecca W Wilson; Malini Rajagopalan; Richard J Wallace
PCR amplification and restriction endonuclease analysis of a 65-kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria.
Journal of clinical microbiology 1995;33(1):149-53.
1994: Y Pang; BA Brown; VA Steingrube; Richard J Wallace; Marilyn C Roberts
Tetracycline resistance determinants in Mycobacterium and Streptomyces species.
Antimicrobial agents and chemotherapy 1994;38(6):1408-12.
1994: Richard J Wallace; BA Brown; David E Griffith; W M Girard; D T Murphy; GO Onyi; VA Steingrube; G H Mazurek
Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
American journal of respiratory and critical care medicine 1994;149(5):1335-41.
1994: Richard J Wallace; D Dunbar; BA Brown; GO Onyi; R Dunlap; C H Ahn; D T Murphy
Rifampin-resistant Mycobacterium kansasii.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;18(5):736-43.
1994: A Meier; Philip Kirschner; Burkhard Springer; VA Steingrube; BA Brown; Richard J Wallace; Erik C Böttger
Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare.
Antimicrobial agents and chemotherapy 1994;38(2):381-4.
1993: Richard J Wallace; V A Silcox; M Tsukamura; BA Brown; J O Kilburn; W Ray Butler; GO Onyi
Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism.
Journal of clinical microbiology 1993;31(12):3231-9.
1993: Richard J Wallace; Yansheng Zhang; BA Brown; Victoria J Fraser; G H Mazurek; S Maloney
DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus.
Journal of clinical microbiology 1993;31(10):2697-701.
1993: Richard J Wallace; D Tanner; P J Brennan; BA Brown
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.
Annals of internal medicine 1993;119(6):482-6.
1993: VA Steingrube; Richard J Wallace; BA Brown; Yansheng Zhang; L C Steele; G Young; D R Nash
Partial characterization of Nocardia farcinica beta-lactamases.
Antimicrobial agents and chemotherapy 1993;37(9):1850-5.
1993: Richard J Wallace; BA Brown; David E Griffith
Drug intolerance to high-dose clarithromycin among elderly patients.
Diagnostic microbiology and infectious disease 1993;16(3):215-21.
1993: G H Mazurek; S Hartman; Yansheng Zhang; BA Brown; J S Hector; D Murphy; Richard J Wallace
Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool.
Journal of clinical microbiology 1993;31(2):390-4.
1992: Yansheng Zhang; Richard J Wallace; VA Steingrube; BA Brown; R Nash; A Silcox; M Tsukamura
Isoelectric focusing patterns of beta-lactamases in the rapidly growing mycobacteria.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1992;73(6):337-44.
1992: BA Brown; Richard J Wallace; GO Onyi
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.
Antimicrobial agents and chemotherapy 1992;36(9):1987-90.
1992: Richard J Wallace; BA Brown; GO Onyi
Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.
The Journal of infectious diseases 1992;166(2):405-12.
1992: J S Hector; Y Pang; G H Mazurek; Yansheng Zhang; BA Brown; Richard J Wallace
Large restriction fragment patterns of genomic Mycobacterium fortuitum DNA as strain-specific markers and their use in epidemiologic investigation of four nosocomial outbreaks.
Journal of clinical microbiology 1992;30(5):1250-5.
1992: BA Brown; Richard J Wallace; GO Onyi; V De Rosas; R J Wallace
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.
Antimicrobial agents and chemotherapy 1992;36(1):180-4.
1991: Marilyn C Roberts; Y J Pang; Robert C Spencer; T G Winstanley; BA Brown; Richard J Wallace
Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis.
Antimicrobial agents and chemotherapy 1991;35(11):2453-5.
1991: Richard J Wallace; BA Brown; M Tsukamura; June M Brown; GO Onyi
Clinical and laboratory features of Nocardia nova.
Journal of clinical microbiology 1991;29(11):2407-11.
1991: Richard J Wallace; BA Brown; GO Onyi
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.
Antimicrobial agents and chemotherapy 1991;35(4):773-5.
1991: VA Steingrube; Richard J Wallace; BA Brown; Y Pang; B Zeluff; L C Steele; Yansheng Zhang
Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
Antimicrobial agents and chemotherapy 1991;35(3):524-8.
1991: Richard J Wallace; BA Brown; V A Silcox; M Tsukamura; D R Nash; L C Steele; VA Steingrube; J Smith; G Sumter; Y S Zhang
Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum.
The Journal of infectious diseases 1991;163(3):598-603.
1990: Richard J Wallace; M Tsukamura; BA Brown; J Brown; VA Steingrube; Y S Zhang; D R Nash
Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica.
Journal of clinical microbiology 1990;28(12):2726-32.
1990: Marilyn C Roberts; BA Brown; VA Steingrube; Richard J Wallace
Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis.
Antimicrobial agents and chemotherapy 1990;34(9):1816-8.
1990: Richard J Wallace; G Bedsole; G Sumter; C V Sanders; L C Steele; BA Brown; J Smith; D R Graham
Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.
Antimicrobial agents and chemotherapy 1990;34(1):65-70.
1989: Richard J Wallace; VA Steingrube; D R Nash; D G Hollis; C Flanagan; BA Brown; A Labidi; R E Weaver
BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.
Antimicrobial agents and chemotherapy 1989;33(11):1845-54.
1989: BA Brown; Richard J Wallace; C W Flanagan; R W Wilson; J I Luman; S D Redditt
Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.
Antimicrobial agents and chemotherapy 1989;33(9):1631-3.